NAD+ Biology & the Sirtuin Pathway: What the Evidence Actually Shows in 2027
June 18, 2027
2:15 pm – 2:45 pm
Room 1
NAD+ has become one of the most commercially exploited molecules in longevity science, but the clinical trial data tells a more nuanced story than the supplement industry admits. Improve how you evaluate and apply NAD+ precursor interventions with confidence. Source practical tips to:
- Master the biology of NAD+ decline and the sirtuin pathway’s role in aging
- Distinguish what peer-reviewed clinical data on NMN and NR actually demonstrates from marketing claims
- Identify where the evidence supports supplementation, and where it doesn’t yet
Achieve a clearer, evidence-based position on NAD+ and make smarter decisions for your longevity practice